Zoetis reported results on November 2nd. The company generated 2.15bn in revenue during the third quarter, growing 7.4% on a yearly basis and exhibiting a 4yr CAGR of 7.9%. Zoetis revenue growth had been decelerating for a couple of quarters, mainly attributable, in my opinion, to the excess demand it experienced during 2021. In an industry that tends to grow at 4-6%, achieving 20-25% growth rates do nothing but pull demand ahead in time. Ever since, growth had slowed and stayed below 5% during 2023.
I think your quarterly reviews are great Giuliano! Detailed but not wordy, and has all the important details. I doubt most equity analysts can do better than you.
Great review! Zoetis have a strong brand recognition inside of the veterinarian world because of the year's of commitment and development. If they can continue this trend, in the long run they should be able to gain market share and competitors will be leave behind.